IL-15 superagonist RLI has potent immunostimulatory properties on NK cells: implications for antimetastatic treatment

Background As the immune system is compromised in patients with cancer, therapeutic strategies to stimulate immunity appear promising, to avoid relapse and increase long-term overall survival. Interleukin-15 (IL-15) has similar properties to IL-2, but does not cause activation-induced cell death nor...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Mélanie Desbois, Coralie Béal, Mélinda Charrier, Benjamin Besse, Guillaume Meurice, Nicolas Cagnard, Yannick Jacques, David Béchard, Lydie Cassard, Nathalie Chaput
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMJ Publishing Group 2020-05-01
coleção:	Journal for ImmunoTherapy of Cancer
Acesso em linha:	https://jitc.bmj.com/content/8/1/e000632.full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!